Today: 21 May 2026
Browse Category

NASDAQ:BCRX 14 October 2025 - 2 March 2026

BioCryst (BCRX) stock price dips premarket as new navenibart HAE data lands; Cowen talk next

BioCryst (BCRX) stock price dips premarket as new navenibart HAE data lands; Cowen talk next

BioCryst Pharmaceuticals shares fell 2.9% to $8.50 premarket Monday after new clinical data on its hereditary angioedema drug pipeline. Interim results from the ALPHA-SOLAR study showed navenibart reduced mean monthly HAE attacks by 91% among 29 patients, with one discontinuation due to cancer. The company reaffirmed 2026 revenue guidance for ORLADEYO and expects a Phase 3 navenibart filing by late 2027.
2 March 2026
·
Astria Therapeutics Stock Skyrockets 53% After $700M Buyout – What’s Next?

Astria Therapeutics Stock Skyrockets 53% After $700M Buyout – What’s Next?

Astria Therapeutics shares surged up to 50% on Oct. 14, 2025, after BioCryst Pharmaceuticals agreed to acquire the company in a cash-and-stock deal valuing ATXS at about $13 per share. Halper Sadeh LLC announced an investigation into the fairness of the sale. Astria’s lead drug navenibart is in Phase 3 trials for hereditary angioedema, with topline data expected in early 2027.
14 October 2025
···

Stock Market Today

  • Actor Niko Foster lists Nevada mansion for $22 million
    May 21, 2026, 5:17 AM EDT. Actor Niko Foster is selling a 14,000-square-foot mansion near Las Vegas for $22 million. The home offers unobstructed views of the Las Vegas Strip and features a range of upscale amenities. Located in an exclusive community, the property stands out for its size and luxury.

Latest articles

Snowflake Heads Toward $205 BofA Level Before Earnings Next Week

Snowflake Heads Toward $205 BofA Level Before Earnings Next Week

21 May 2026
Snowflake shares fell 1.5% to $166.97 in early Thursday trading after Bank of America raised its price target to $205 and reiterated a Buy rating ahead of fiscal Q1 results due May 27. RBC cut its target earlier this week, highlighting ongoing competition in data and AI. Snowflake previously guided for Q1 product revenue of $1.262–$1.267 billion, up 27% year-over-year.
Arm jumps in premarket on AI chip hopes

Arm jumps in premarket on AI chip hopes

21 May 2026
Arm Holdings shares closed Wednesday at $256.73, up 15.05%, after Bernstein’s David Dai initiated coverage with an outperform rating and a $300 target, citing rising demand for server CPUs driven by agentic AI. The stock touched $259.44 during regular trading. U.S. markets were open; May 21 is not a listed exchange holiday. Arm’s AGI CPU has over $2 billion in expected demand for fiscal 2027 and 2028.
T1 Energy Stock Jumps 26% as Roth Pushback Turns Short-Seller Hit Into a Rally

T1 Energy Stock Jumps 26% as Roth Pushback Turns Short-Seller Hit Into a Rally

21 May 2026
T1 Energy Inc. shares jumped 26.45% to $8.70 Wednesday after heavy trading and recent volatility. The move follows a short-seller report alleging hidden Chinese ties and tax-credit risks, countered by a Roth Capital analyst’s defense and news of a major institutional stake. T1 reported a $21.4 million net loss but positive adjusted EBITDA and maintained its 2026 production guidance.
Go toTop